Bioventix Plc Holding(s) in Company

 
TIDMBVXP 
 
For filings with the FCA include the annex 
 
For filings with issuer exclude the annex 
 
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi 
 
1. Identity of the issuer or the underlying issuer                          Bioventix 
of existing shares to which voting rights are                                (Sedol 
attached: ii                                                                B4QVDF0) 
 
2 Reason for the notification (please tick the appropriate box or boxes): 
 
An acquisition or disposal of voting rights                                                      X 
 
An acquisition or disposal of qualifying financial instruments which may result 
in the acquisition of shares already issued to which voting rights are attached 
 
An acquisition or disposal of instruments with similar economic effect to 
qualifying financial instruments 
 
An event changing the breakdown of voting rights 
 
Other (please 
specify): 
 
3. Full name of person(s) subject to                 CASTLEFIELD FUND PARTNERS LIMITED 
the 
notification obligation: iii 
 
4. Full name of shareholder(s) 
 (if different from 3.):iv 
 
5. Date of the transaction and date                                                   9th  January 2017 
on 
which the threshold is crossed or 
reached: v 
 
6. Date on which issuer notified: 
                                                             12th January 2017 
 
7. Threshold(s) that is/are crossed                                                                  5% 
or 
reached: vi, vii 
 
 
 
 
8. Notified details: 
 
A: Voting rights attached to shares viii, ix 
 
Class/type of    Situation previous        Resulting situation after the triggering transaction 
shares           to the triggering 
                 transaction 
if possible 
using            Number       Number       Number      Number of voting      % of  voting rights x 
the ISIN CODE    of           of           of shares   rights 
                 Shares       Voting 
                              Rights       Direct      Direct xi  Indirect   Direct       Indirect 
                                                                  xii 
 
                   250,000      250,000      265,000    265,000                 5.197% 
  GB00B4QVDF07 
 
B: Qualifying Financial Instruments 
 
Resulting situation after the triggering transaction 
 
Type of financial       Expiration Exercise/               Number of voting        % of voting 
instrument              date xiii  Conversion Period xiv   rights that may be      rights 
                                                           acquired if the 
                                                           instrument is 
                                                           exercised/ converted. 
 
C: Financial Instruments with similar economic effect to Qualifying Financial 
Instruments xv, xvi 
 
Resulting situation after the triggering transaction 
 
Type of financial  Exercise   Expiration Exercise/     Number of voting rights  % of voting rights 
instrument         price      date xvii  Conversion    instrument refers to     xix, xx 
                                         period xviii 
 
                                                                                Nominal      Delta 
 
Total (A+B+C) 
 
Number of voting rights                          Percentage of voting rights 
 
265,000                                          5.197% 
 
 
 
 
9. Chain of controlled undertakings through which the voting rights and/or the 
financial instruments are effectively held, if applicable: xxi 
 
Proxy Voting: 
 
10. Name of the proxy holder: 
 
11. Number of voting rights proxy holder will cease 
to hold: 
 
12. Date on which proxy holder will cease to hold 
voting rights: 
 
 
13. Additional information:                      Percentage based on Issued Share Capital of 
                                                                                  5,098,656 
 
14. Contact name:                                                            Richard Vickers 
 
15. Contact telephone number:                                                  0161 233 4890 
 
 
 
 
Note: Annex should only be submitted to the FSA not the issuer 
 
Annex: Notification of major interests in sharesxxii 
 
A: Identity of the persons or legal entity subject to the notification 
obligation 
 
Full name 
(including legal form of legal entities) 
 
Contact address 
(registered office for legal entities) 
 
Phone number & email 
 
Other useful information 
(at least legal representative for legal 
persons) 
 
B: Identity of the notifier, if applicable 
 
Full name 
 
Contact address 
 
Phone number & email 
 
Other useful information 
(e.g. functional relationship with the 
person or legal entity subject to the 
notification obligation) 
 
C: Additional information 
 
For notes on how to complete form TR-1 please see the FSA website. 
 
 
 
END 
 

(END) Dow Jones Newswires

January 13, 2017 10:55 ET (15:55 GMT)